TGFB1 and prostate cancer: To the best of our knowledge, the present study is the first to report the serum levels of TGF-β1 determined before radiotherapy and after the 25th radiotherapy fraction in prostate cancer patients to be significantly positively associated with acute GU radiotoxicity symptoms.